# David Smoller

> David Smoller is a Series A investor at Cultivation Capital backing Health Care and Biotechnology. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cultivation Capital](https://shizune.co/investors/profile/cultivation-capital)
- Location: St Louis, United States
- Total investments: 5
- Last investment: Mar 2016
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/dave-smoller-395517

David Smoller is a Series A investor at Cultivation Capital in St Louis focused on Health Care and Biotechnology. Dr. David A. Smoller is a General Partner at Cultivation Capital. He previously worked at Horizon Discovery as a Chief Business Officer and Board Member. David Smoller attended Emory University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| Biotechnology | 2 | 40% |
| Life Science | 1 | 20% |
| Clinical Trials | 1 | 20% |
| Health Diagnostics | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 40% |
| Series B | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Adarza BioSystems | Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip.It was founded in 2008 and headquartered in St Louis, Missouri. | $5M | Series B | Mar 21, 2016 |  |
| ImmunoPhotonics | ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri. |  | Series A | Jan 26, 2015 |  |
| Adarza BioSystems | Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip.It was founded in 2008 and headquartered in St Louis, Missouri. | $4M | Series A | Oct 02, 2014 |  |
| ImmunoPhotonics | ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a strategic partnership with Veterinary Cancer Therapeutics, LLC. The company was founded in 2008 and is based in Columbia, Missouri. |  | Series A | Sep 03, 2014 |  |
| Adarza BioSystems | Adarza BioSystems is an early-stage medical diagnostics company developing a rapid and label-free biological assay platform for measuring clinical and point-of-care (POC) samples. In addition to performing sophisticated clinical tests within minutes, this technology potentially allowing hundreds of tests to be run simultaneously on a single chip.It was founded in 2008 and headquartered in St Louis, Missouri. | $2M | Series A | Jul 09, 2014 |  |

5 of 5 investments shown.

## Co-investors
- [BioGenerator](https://shizune.co/investors/profile/biogenerator) — VC Fund, 2 deals together
- [iSelect Fund](https://shizune.co/investors/profile/iselectfund) — VC Fund, 2 deals together
- [N47](https://shizune.co/investors/profile/next47) — VC Fund, 2 deals together
- [Serra Ventures](https://shizune.co/investors/profile/serra-ventures) — VC Fund, 2 deals together
- [Argonautic Ventures](https://shizune.co/investors/profile/argonautic-ventures) — VC Fund, 1 deal together
- [Billiken Angels Network](https://shizune.co/investors/profile/billiken-angels-network) — VC Fund, 1 deal together

## About Cultivation Capital

VC Fund · St Louis, United States

Cultivation Capital is a venture capital firm that manages a family of funds focused on early-stage investing. Most of our initial investments are during a startup’s Seed or Series A phase, and our initial checks range from $500k – $3.5M. Our industries of focus include life sciences and health tech, software and IT, agriculture tech, andgeospatial tech.

5 contacts available at Cultivation Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Alana Mann | Principal | https://shizune.co/investors/profile/alana-mann |
| Andy Dearing | General Partner | https://shizune.co/investors/profile/andy-dearing |
| Brian Matthews | Co-Founder & General Partner | https://shizune.co/investors/profile/brian-matthews |
| David Smoller | General Partner - Life Sciences Fund | https://shizune.co/investors/profile/david-smoller |
| Dean VandeKamp | General Partner | https://shizune.co/investors/profile/dean-vandekamp |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does David Smoller invest in?

David Smoller invests primarily in Health Care, Biotechnology and Life Science startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did David Smoller last invest?

The most recent investment recorded for David Smoller closed in Mar 2016. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co